{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:30:13Z","timestamp":1786995013915,"version":"build-2736575974"},"reference-count":481,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"am","delay-in-days":300,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006462","name":"City University of New York","doi-asserted-by":"publisher","award":["TRADB-49-271"],"award-info":[{"award-number":["TRADB-49-271"]}],"id":[{"id":"10.13039\/100006462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM123508"],"award-info":[{"award-number":["R01GM123508"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24 DA018055"],"award-info":[{"award-number":["R24 DA018055"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.niox.2022.08.003","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T03:20:23Z","timestamp":1661311223000},"page":"72-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Utility of NO and H2S donating platforms in managing COVID-19: Rationale and promise"],"prefix":"10.1016","volume":"128","author":[{"given":"Palak P.","family":"Oza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4060-7283","authenticated-orcid":false,"given":"Khosrow","family":"Kashfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2022.08.003_bib1","series-title":"Molecular Virology of Human Pathogenic Viruses","first-page":"289","article-title":"Chapter 21 - new emerging viruses","author":"Ryu","year":"2017"},{"key":"10.1016\/j.niox.2022.08.003_bib2","doi-asserted-by":"crossref","unstructured":"B.W.J. Mahy, Emerging and Reemerging Virus Diseases of Vertebrates\u2606, Reference Module in Biomedical Sciences, Elsevier2014.","DOI":"10.1016\/B978-0-12-801238-3.02564-2"},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2022.08.003_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1533\/9780857098870.4.442","article-title":"Epidemiology, control, and prevention of emerging zoonotic viruses","author":"Santos","year":"2013","journal-title":"Viruses in Food and Water"},{"key":"10.1016\/j.niox.2022.08.003_bib5","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.jfma.2021.05.015","article-title":"Effectiveness of non-pharmaceutical interventions and vaccine for containing the spread of COVID-19: three illustrations before and after vaccination periods","volume":"120","author":"Lin","year":"2021","journal-title":"J. Formos. Med. Assoc."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib6","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.dsx.2020.06.024","article-title":"Analyzing barriers for implementation of public health and social measures to prevent the transmission of COVID-19 disease using DEMATEL method","volume":"14","author":"Maqbool","year":"2020","journal-title":"Diabetes Metabol. Syndr."},{"key":"10.1016\/j.niox.2022.08.003_bib7","series-title":"Synthesis of Best-Seller Drugs","first-page":"687","article-title":"Chapter 34 - antiviral drugs","author":"Vardanyan","year":"2016"},{"key":"10.1016\/j.niox.2022.08.003_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01207","article-title":"The signaling pathways, and therapeutic targets of antiviral agents: focusing on the antiviral approaches and clinical Perspectives of anthocyanins in the management of viral diseases","volume":"10","author":"Mohammadi Pour","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ja.2017.115","article-title":"Current landscape and future prospects of antiviral drugs derived from microbial products","volume":"71","author":"Takizawa","year":"2018","journal-title":"J. Antibiot."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/dkaa442","article-title":"Treating COVID-19: are we missing out the window of opportunity?","volume":"76","author":"Sundararaj Stanleyraj","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/v13040667","article-title":"Broad-spectrum antiviral strategies and nucleoside analogues","volume":"13","author":"Geraghty","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik Jennifer","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00011-016-0996-0","article-title":"The inflammatory response triggered by Influenza virus: a two edged sword","volume":"66","author":"Tavares","year":"2017","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.chest.2017.12.005","article-title":"The burden of viruses in pneumonia associated with acute respiratory failure: an underappreciated issue","volume":"154","author":"Shorr","year":"2018","journal-title":"Chest"},{"issue":"140","key":"10.1016\/j.niox.2022.08.003_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1183\/16000617.0076-2015","article-title":"Viral infection in community-acquired pneumonia: a systematic review and meta-analysis","volume":"25","author":"Burk","year":"2016","journal-title":"Eur. Respir. Rev."},{"issue":"12, Part 2","key":"10.1016\/j.niox.2022.08.003_bib16","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1016\/j.lpm.2011.05.027","article-title":"Virus-induced acute respiratory distress syndrome: epidemiology, management and outcome","volume":"40","author":"Luyt","year":"2011","journal-title":"Presse Med."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ejrad.2010.12.085","article-title":"Computed tomography findings from patients with ARDS due to Influenza A (H1N1) virus-associated pneumonia","volume":"81","author":"Grieser","year":"2012","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.niox.2022.08.003_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.coviro.2014.06.006","article-title":"Virus interactions with endothelial cell receptors: implications for viral pathogenesis","volume":"7","author":"Dalrymple","year":"2014","journal-title":"Current Opinion in Virology"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/sj.bmt.1703879","article-title":"Endothelial damage caused by cytomegalovirus and human herpesvirus-6","volume":"31","author":"Takatsuka","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4161\/viru.25779","article-title":"Endothelial activation and dysfunction in the pathogenesis of influenza A virus infection","volume":"4","author":"Armstrong","year":"2013","journal-title":"Virulence"},{"issue":"10","key":"10.1016\/j.niox.2022.08.003_bib21","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/jmv.23354","article-title":"Review: viral infections and mechanisms of thrombosis and bleeding","volume":"84","author":"Goeijenbier","year":"2012","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.niox.2022.08.003_bib22","doi-asserted-by":"crossref","DOI":"10.2147\/IJGM.S265865","article-title":"Extracellular vesicle-related thrombosis in viral infection","volume":"13","author":"Nomura","year":"2020","journal-title":"Int. J. Gen. Med."},{"issue":"4579140.","key":"10.1016\/j.niox.2022.08.003_bib23","first-page":"1","article-title":"An update on hydrogen sulfide and nitric oxide interactions in the cardiovascular system","volume":"2018","author":"Wu","year":"2018","journal-title":"Oxid Med Cell Longev 2018"},{"key":"10.1016\/j.niox.2022.08.003_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.niox.2014.05.014","article-title":"Hydrogen sulfide and nitric oxide interactions in inflammation","volume":"41","author":"Lo Faro","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2022.08.003_bib25","series-title":"Corona Virus Resource Center","author":"Johns-Hopkins-University-Medicine","year":"2022"},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s15010-020-01486-5","article-title":"Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases","volume":"48","author":"Rossi","year":"2020","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249090","article-title":"Magnitude of asymptomatic COVID-19 cases throughout the course of infection: a systematic review and meta-analysis","volume":"16","author":"Alene","year":"2021","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.niox.2022.08.003_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37257","article-title":"Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis","volume":"4","author":"Ma","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246190","article-title":"The prognostic value of comorbidity for the severity of COVID-19: a systematic review and meta-analysis study","volume":"16","author":"Fathi","year":"2021","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1016\/j.niox.2022.08.003_bib30","article-title":"Comorbidities and mortality in COVID-19 patients","volume":"35","author":"Djaharuddin","year":"2021","journal-title":"Gac. Sanit."},{"issue":"11","key":"10.1016\/j.niox.2022.08.003_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.34147","article-title":"Disparities in COVID-19 outcomes by race, ethnicity, and socioeconomic status: a systematic review and meta-analysis","volume":"4","author":"Magesh","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.niox.2022.08.003_bib32","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04474-2020","article-title":"Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study","author":"Beltramo","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.niox.2022.08.003_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102792","article-title":"Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy","volume":"127","author":"Haque","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.niox.2022.08.003_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106239","article-title":"Pulmonary pathology of ARDS in COVID-19: a pathological review for clinicians","volume":"176","author":"Batah","year":"2021","journal-title":"Respir. Med."},{"issue":"10","key":"10.1016\/j.niox.2022.08.003_bib35","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1007\/s42399-020-00498-4","article-title":"COVID-19 and its modes of transmission","volume":"2","author":"Karia","year":"2020","journal-title":"SN Comprehensive Clinical Medicine"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa021","article-title":"The reproductive number of COVID-19 is higher compared to SARS coronavirus","volume":"27","author":"Liu","year":"2020","journal-title":"J. Trav. Med."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib37","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/jmv.27588","article-title":"Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines","volume":"94","author":"Araf","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.niox.2022.08.003_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106261","article-title":"The Omicron subvariant BA.2: birth of a new challenge during the COVID-19 pandemic","volume":"99","author":"Rahimi","year":"2022","journal-title":"Int. J. Surg."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.rce.2020.08.005","article-title":"Incubation period of COVID-19: a systematic review and meta-analysis","volume":"221","author":"Quesada","year":"2021","journal-title":"Rev. Cl\u00ednica Espa\u00f1ola"},{"key":"10.1016\/j.niox.2022.08.003_bib40","first-page":"1","article-title":"Incubation period for COVID-19: a systematic review and meta-analysis","volume":"Feb 23","author":"Rai","year":"2021","journal-title":"J. Publ. Health"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib41","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2666-5247(20)30172-5","article-title":"SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis","volume":"2","author":"Cevik","year":"2021","journal-title":"The Lancet Microbe"},{"issue":"7798","key":"10.1016\/j.niox.2022.08.003_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2020.10.005","article-title":"COVID-19 \u2013 a vascular disease","volume":"31","author":"Siddiqi","year":"2021","journal-title":"Trends Cardiovasc. Med."},{"issue":"14","key":"10.1016\/j.niox.2022.08.003_bib48","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/ars.2020.8247","article-title":"N-acetylcysteine and hydrogen sulfide in coronavirus disease 2019","volume":"35","author":"Bourgonje","year":"2021","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.niox.2022.08.003_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117905","article-title":"Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: therapeutic implications","volume":"256","author":"Banu","year":"2020","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib50","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib51","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"7047","key":"10.1016\/j.niox.2022.08.003_bib52","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.niox.2022.08.003_bib53","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57149","article-title":"Evidence for transmission of COVID-19 prior to symptom onset","volume":"9","author":"Tindale","year":"2020","journal-title":"Elife"},{"issue":"15","key":"10.1016\/j.niox.2022.08.003_bib54","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/cid\/ciaa316","article-title":"COVID-19 transmission within a family cluster by presymptomatic carriers in China","volume":"71","author":"Qian","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"30","key":"10.1016\/j.niox.2022.08.003_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2008373117","article-title":"The implications of silent transmission for the control of COVID-19 outbreaks","volume":"117","author":"Moghadas","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib56","first-page":"40","article-title":"The importance of understanding the stages of COVID-19 in treatment and trials","volume":"23","author":"Griffin","year":"2021","journal-title":"AIDS Rev."},{"issue":"11","key":"10.1016\/j.niox.2022.08.003_bib57","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41379-020-0603-3","article-title":"A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression","volume":"33","author":"Polak","year":"2020","journal-title":"Mod. Pathol."},{"issue":"22","key":"10.1016\/j.niox.2022.08.003_bib58","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2020.22717","article-title":"A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications","volume":"324","author":"Datta","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and multiorgan response","volume":"45","author":"Zaim","year":"2020","journal-title":"Curr. Probl. Cardiol."},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.46234\/ccdcw2020.032","article-title":"Novel coronavirus pneumonia emergency response epidemiology, the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020","volume":"2","author":"The","year":"2020","journal-title":"China CDC Wkly"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib61","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jinf.2020.04.004","article-title":"CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China","volume":"81","author":"Meng","year":"2020","journal-title":"J. Infect."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib62","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.21037\/apm-20-1863","article-title":"Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis","volume":"10","author":"Xie","year":"2021","journal-title":"Ann. Palliat. Med."},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib63","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03240-7","article-title":"Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey","volume":"24","author":"Tzotzos","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.niox.2022.08.003_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.579788","article-title":"Nitric oxide releasing hydrogel nanoparticles decreases epithelial cell injuries associated with airway reopening","volume":"8","author":"Shurbaji","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246318","article-title":"COVID-19 ICU and mechanical ventilation patient characteristics and outcomes\u2014a systematic review and meta-analysis","volume":"16","author":"Chang","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202006-2405OC","article-title":"Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation. A meta-analysis","volume":"203","author":"Lim","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib68","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13613-020-00775-4","article-title":"Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study","volume":"10","author":"Luyt","year":"2020","journal-title":"Ann. Intensive Care"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib69","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00134-020-06323-9","article-title":"V.s.G. on behalf of the co, Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study","volume":"47","author":"Rouz\u00e9","year":"2021","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s42399-021-01114-9","article-title":"Evaluation of bacterial coinfection and antibiotic resistance in patients with COVID-19 under mechanical ventilation","volume":"4","author":"Jamnani","year":"2022","journal-title":"SN Comprehensive Clinical Medicine"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary embolism in patients with COVID-19","volume":"142","author":"Poissy","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2022.08.003_bib72","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib73","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemostasis"},{"issue":"10229","key":"10.1016\/j.niox.2022.08.003_bib74","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jamcollsurg.2020.05.007","article-title":"Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection","volume":"231","author":"Wright","year":"2020","journal-title":"J. Am. Coll. Surg."},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib76","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib77","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/M20-0533","article-title":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19","volume":"172","author":"Zhang","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib78","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2022.08.003_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib80","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.1148\/radiol.2020200823","article-title":"Performance of radiologists in differentiating COVID-19 from non-COVID-19 viral pneumonia at chest CT","volume":"296","author":"Bai","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.niox.2022.08.003_bib81","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaci.2020.08.031","article-title":"Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19","volume":"147","author":"Sims","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6504","key":"10.1016\/j.niox.2022.08.003_bib83","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib84","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/cid\/ciaa410","article-title":"Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19","volume":"71","author":"Chu","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib85","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib86","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40560-020-00453-4","article-title":"Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis","volume":"8","author":"Huang","year":"2020","journal-title":"Journal of Intensive Care"},{"issue":"15","key":"10.1016\/j.niox.2022.08.003_bib87","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib88","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"18","key":"10.1016\/j.niox.2022.08.003_bib89","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.niox.2022.08.003_bib90","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105896","article-title":"Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage","volume":"39","author":"Chen","year":"2020","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib91","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib92","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","article-title":"Characterization of the inflammatory response to severe COVID-19 illness","volume":"202","author":"McElvaney","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.niox.2022.08.003_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102763","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","volume":"55","author":"Liu","year":"2020","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib94","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib95","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10456-020-09730-0","article-title":"Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients","volume":"23","author":"Smadja","year":"2020","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib96","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/rmv.1818","article-title":"Endothelial dysfunction in dengue virus pathology","volume":"25","author":"Vervaeke","year":"2015","journal-title":"Rev. Med. Virol."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib97","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1152\/physiol.00059.2013","article-title":"You're only as old as your arteries: translational strategies for preserving vascular endothelial function with aging","volume":"29","author":"Seals","year":"2014","journal-title":"Physiology"},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib98","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/nutrit\/nuz025","article-title":"Effects of dietary nitrate on inflammation and immune function, and implications for cardiovascular health","volume":"77","author":"Raubenheimer","year":"2019","journal-title":"Nutr. Rev."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib99","first-page":"202","article-title":"Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients","volume":"6","author":"Canzano","year":"2021","journal-title":"JACC (J. Am. Coll. Cardiol.): Basic to Translational Science"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/a-1551-9911","article-title":"Mild COVID-19 and impaired blood cell-endothelial crosstalk: considering long-term use of antithrombotics?","volume":"122","author":"Melkumyants","year":"2022","journal-title":"Thromb. Haemostasis"},{"issue":"10234","key":"10.1016\/j.niox.2022.08.003_bib101","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib102","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cardiores.2004.06.020","article-title":"Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress","volume":"64","author":"Clapp","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40292-016-0133-8","article-title":"Endothelial dysfunction in obesity: role of inflammation","volume":"23","author":"Virdis","year":"2016","journal-title":"High Blood Pres. Cardiovasc. Prev."},{"key":"10.1016\/j.niox.2022.08.003_bib104","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/792393","article-title":"Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus","volume":"2010","author":"van den Oever","year":"2010","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib105","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.114.03575","article-title":"Endothelial dysfunction and hypertension","volume":"64","author":"Brandes","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.niox.2022.08.003_bib106","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2020.10.014","article-title":"Endothelial dysfunction in COVID-19: current findings and therapeutic implications","volume":"314","author":"N\u00e4gele","year":"2020","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib107","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patients after acute COVID-19","volume":"324","author":"Carf\u00ec","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib108","first-page":"116","article-title":"Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection","volume":"6","author":"Rajpal","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib109","first-page":"869","article-title":"Long COVID: an overview, diabetes & metabolic syndrome","volume":"15","author":"Raveendran","year":"2021","journal-title":"Clin. Res. Rev."},{"key":"10.1016\/j.niox.2022.08.003_bib110","article-title":"Nitric oxide and viral infection: recent developments in antiviral therapies and platforms","volume":"22","author":"Garren","year":"2021","journal-title":"Appl. Mater. Today"},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003895","article-title":"Nitric oxide to fight viral infections","volume":"8","author":"Lisi","year":"2021","journal-title":"Adv. Sci."},{"issue":"30","key":"10.1016\/j.niox.2022.08.003_bib112","doi-asserted-by":"crossref","first-page":"18709","DOI":"10.1074\/jbc.273.30.18709","article-title":"Diffusion-limited reaction of free nitric oxide with erythrocytes","volume":"273","author":"Liu","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib113","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1073\/pnas.98.1.355","article-title":"The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2","volume":"98","author":"Thomas","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib114","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1088\/0967-3334\/17\/4\/004","article-title":"Half-life of nitric oxide in aqueous solutions with and without haemoglobin","volume":"17","author":"Hakim","year":"1996","journal-title":"Physiol. Meas."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.niox.2009.07.002","article-title":"What is the real physiological NO concentration in vivo?","volume":"21","author":"Hall","year":"2009","journal-title":"Nitric Oxide : biology and chemistry"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010056","article-title":"Human nitric oxide synthase\u2014its functions, polymorphisms, and inhibitors in the context of inflammation, diabetes and cardiovascular diseases","volume":"22","author":"Kr\u00f3l","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib117","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1574-695X.2007.00329.x","article-title":"The role of nitric oxide in inflammatory reactions","volume":"51","author":"Tripathi","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"14","key":"10.1016\/j.niox.2022.08.003_bib118","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1242\/jcs.01166","article-title":"iNOS (NOS2) at a glance","volume":"117","author":"Lowenstein","year":"2004","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.freeradbiomed.2006.01.037","article-title":"Role of epithelial nitric oxide in airway viral infection","volume":"41","author":"Xu","year":"2006","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.00034.2003","article-title":"Nitric oxide in health and disease of the respiratory system","volume":"84","author":"Ricciardolo","year":"2004","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib121","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2125.2012.04420.x","article-title":"Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway","volume":"75","author":"Lidder","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.niox.2022.08.003_bib122","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2020.12.008","article-title":"The role of NO in COVID-19 and potential therapeutic strategies","volume":"163","author":"Fang","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib123","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrd2466","article-title":"The nitrate\u2013nitrite\u2013nitric oxide pathway in physiology and therapeutics","volume":"7","author":"Lundberg","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib124","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.freeradbiomed.2004.04.027","article-title":"Inorganic nitrate is a possible source for systemic generation of nitric oxide","volume":"37","author":"Lundberg","year":"2004","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/3228","article-title":"Discovery of the nitric oxide signaling pathway and targets for drug development","volume":"14","author":"Bryan","year":"2009","journal-title":"Front. Biosci."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib126","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cardiores.2007.04.014","article-title":"Inhaled NO as a therapeutic agent","volume":"75","author":"Bloch","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib127","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1113\/expphysiol.1997.sp004029","article-title":"Role of nitric oxide in regulation of leucocyte-endothelial cell interactions","volume":"82","author":"Hickey","year":"1997","journal-title":"Exp. Physiol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.freeradbiomed.2011.04.010","article-title":"Nitric oxide signaling: classical, less classical, and nonclassical mechanisms","volume":"51","author":"Mart\u00ednez-Ruiz","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2022.08.003_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2018.08.002","article-title":"Don't just say no: differential pathways and pharmacological responses to diverse nitric oxide donors","volume":"156","author":"Chiesa","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib130","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13443","article-title":"Nitric oxide: to be or not to be an endocrine hormone?","volume":"229","author":"Bahadoran","year":"2020","journal-title":"Acta Physiol."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib131","first-page":"469","article-title":"Nitric oxide and superoxide in inflammation and immune regulation","volume":"54","author":"Guzik","year":"2003","journal-title":"J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib132","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.4049\/jimmunol.166.6.3873","article-title":"Biphasic regulation of NF-\u03baB activity underlies the pro- and anti-inflammatory actions of nitric oxide","volume":"166","author":"Connelly","year":"2001","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib133","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10787-007-0013-x","article-title":"Role of nitric oxide in inflammatory diseases","volume":"15","author":"Sharma","year":"2007","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib134","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4161\/viru.20328","article-title":"The potential of nitric oxide releasing therapies as antimicrobial agents","volume":"3","author":"Schairer","year":"2012","journal-title":"Virulence"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2478\/v10102-011-0012-z","article-title":"Biochemical aspects of nitric oxide synthase feedback regulation by nitric oxide","volume":"4","author":"Kopincov\u00e1","year":"2011","journal-title":"Interdiscipl. Toxicol."},{"issue":"342","key":"10.1016\/j.niox.2022.08.003_bib136","doi-asserted-by":"crossref","first-page":"ra87","DOI":"10.1126\/scisignal.2005478","article-title":"The coordination of S-sulfhydration, S-nitrosylation, and phosphorylation of endothelial nitric oxide synthase by hydrogen sulfide","volume":"7","author":"Altaany","year":"2014","journal-title":"Sci. Signal."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib137","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.lfs.2003.10.042","article-title":"iNOS-mediated nitric oxide production and its regulation","volume":"75","author":"Aktan","year":"2004","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib138","doi-asserted-by":"crossref","first-page":"H2144","DOI":"10.1152\/ajpheart.00591.2005","article-title":"Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes","volume":"289","author":"Nagareddy","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.niox.2022.08.003_bib139","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1417981","article-title":"Role of the eNOS uncoupling and the nitric oxide metabolic pathway in the pathogenesis of autoimmune rheumatic diseases","volume":"2020","author":"\u0141uczak","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib140","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/HYPERTENSIONAHA.109.138305","article-title":"Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome","volume":"54","author":"Marchesi","year":"2009","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib141","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11906-003-0055-4","article-title":"Endothelial nitric oxide synthase and endothelial dysfunction","volume":"5","author":"Huang","year":"2003","journal-title":"Curr. Hypertens. Rep."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib142","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1183\/09031936.95.08020295","article-title":"Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections","volume":"8","author":"Kharitonov","year":"1995","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib143","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41390-019-0281-3","article-title":"Inhibition of endogenous hydrogen sulfide production improves viral elimination in CVB3-infected myocardium in mice","volume":"85","author":"Hua","year":"2019","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib144","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.4049\/jimmunol.166.5.3533","article-title":"Role of nitric oxide synthase type 2 in acute infection with murine cytomegalovirus","volume":"166","author":"Noda","year":"2001","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0002-9440(10)64252-6","article-title":"Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons","volume":"161","author":"Kosugi","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib146","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/viro.2000.0801","article-title":"A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection","volume":"281","author":"Flodstr\u00f6m","year":"2001","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib147","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/adc.75.4.323","article-title":"Exhaled nitric oxide in paediatric asthma and cystic fibrosis","volume":"75","author":"Lundberg","year":"1996","journal-title":"Arch. Dis. Child."},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib148","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1183\/09031936.94.07081501","article-title":"Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome","volume":"7","author":"Lundberg","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.niox.2022.08.003_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101982","article-title":"Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19","volume":"43","author":"Dominic","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.niox.2022.08.003_bib150","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/jmv.27500","article-title":"Total antioxidant capacity as a marker of severity of COVID-19 infection: possible prognostic and therapeutic clinical application","volume":"94","author":"Yaghoubi","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.niox.2022.08.003_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173494","article-title":"Application of methylene blue -vitamin C \u2013N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial","volume":"885","author":"Alamdari","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.niox.2022.08.003_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174306","article-title":"Effects of antiviral drug therapy on dynamic thiol\/disulphide homeostasis and nitric oxide levels in COVID-19 patients","volume":"907","author":"Mete","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.niox.2022.08.003_bib153","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2021.08.237","article-title":"Serum nitrite and nitrate: a potential biomarker for post-covid-19 complications?","volume":"175","author":"Wang","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"22","key":"10.1016\/j.niox.2022.08.003_bib154","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.221381098","article-title":"Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action","volume":"98","author":"Lauer","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.freeradbiomed.2005.08.025","article-title":"Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans","volume":"40","author":"Kleinbongard","year":"2006","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10091350","article-title":"Alveolar nitric oxide as a biomarker of COVID-19 lung sequelae: a pivotal study","volume":"10","author":"Cameli","year":"2021","journal-title":"Antioxidants"},{"issue":"4\u20135","key":"10.1016\/j.niox.2022.08.003_bib157","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.micinf.2020.05.002","article-title":"Could nasal nitric oxide help to mitigate the severity of COVID-19?","volume":"22","author":"Martel","year":"2020","journal-title":"Microb. Infect."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib158","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nm0495-370","article-title":"High nitric oxide production in human paranasal sinuses","volume":"1","author":"Lundberg","year":"1995","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib159","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1074-7613(03)00114-6","article-title":"Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis","volume":"18","author":"Zheng","year":"2003","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib160","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.drudis.2020.10.027","article-title":"Nitric oxide-releasing compounds for the treatment of lung infections","volume":"26","author":"Chiarelli","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib161","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1172\/JCI116479","article-title":"Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication","volume":"91","author":"Croen","year":"1993","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib162","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3109\/00016489709113468","article-title":"Low levels of nasal nitric oxide (NO) correlate to impaired mucociliary function in the upper airways","volume":"117","author":"Lindberg","year":"1997","journal-title":"Acta Otolaryngol."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib163","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0194-5998(98)70063-4","article-title":"Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract","volume":"119","author":"Myers","year":"1998","journal-title":"Otolaryngology-Head Neck Surg. (Tokyo)"},{"issue":"17","key":"10.1016\/j.niox.2022.08.003_bib164","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1016\/j.yexcr.2011.07.007","article-title":"Regulation of ciliary beat frequency by the nitric oxide signaling pathway in mouse nasal and tracheal epithelial cells","volume":"317","author":"Jiao","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1165\/ajrcmb.23.2.4022","article-title":"Regulation of ciliary beat frequency by the nitric oxide\u2013cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells","volume":"23","author":"Li","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib166","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/bbrc.1993.1187","article-title":"Modulation of airway epithelial cell ciliary beat frequency by nitric oxide","volume":"191","author":"Jain","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib167","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0034-5687(95)00042-C","article-title":"Nitric oxide regulation of glycoconjugate secretion from feline and human airways in vitro","volume":"102","author":"Nagaki","year":"1995","journal-title":"Respir. Physiol."},{"issue":"10","key":"10.1016\/j.niox.2022.08.003_bib168","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.73.10.8880-8883.1999","article-title":"Inhibition of influenza virus replication by nitric oxide","volume":"73","author":"Rimmelzwaan","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.niox.2022.08.003_bib169","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.niox.2013.03.007","article-title":"Gaseous nitric oxide reduces influenza infectivity in vitro","volume":"31","author":"Regev-Shoshani","year":"2013","journal-title":"Nitric Oxide"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib170","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02630-20","article-title":"Nitric oxide circumvents virus-mediated metabolic regulation during human cytomegalovirus infection","volume":"11","author":"Mokry","year":"2020","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib171","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jmv.20093","article-title":"Early inhibition of nitric oxide production increases HSV-1 intranasal infection","volume":"73","author":"Gamba","year":"2004","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib172","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.72.2.934-942.1998","article-title":"Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line","volume":"72","author":"Sanders","year":"1998","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.niox.2022.08.003_bib173","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/eji.200535587","article-title":"Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions","volume":"36","author":"Klingstr\u00f6m","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib174","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1172\/JCI119702","article-title":"Nitric oxide inhibition of coxsackievirus replication in vitro","volume":"100","author":"Zaragoza","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib175","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1128\/jvi.71.7.5227-5235.1997","article-title":"Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication","volume":"71","author":"Lin","year":"1997","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib176","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/jvi.69.2.910-915.1995","article-title":"Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication","volume":"69","author":"Harris","year":"1995","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib177","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1128\/JVI.79.3.1966-1969.2005","article-title":"Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus","volume":"79","author":"Akerstr\u00f6m","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2009.09.007","article-title":"Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected","volume":"395","author":"Akerstr\u00f6m","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.niox.2022.08.003_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101734","article-title":"Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro","volume":"37","author":"Akaberi","year":"2020","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijid.2004.04.012","article-title":"Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound","volume":"8","author":"Keyaerts","year":"2004","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib181","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1074-7613(00)80003-5","article-title":"An antiviral mechanism of nitric oxide: inhibition of a viral protease","volume":"10","author":"Saura","year":"1999","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib182","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1006\/bbrc.1999.0581","article-title":"Nitric oxide inhibits the HIV-1 reverse transcriptase activity","volume":"258","author":"Persichini","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Pt 10","key":"10.1016\/j.niox.2022.08.003_bib183","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1099\/vir.0.81880-0","article-title":"Antiviral action of nitric oxide on dengue virus type 2 replication","volume":"87","author":"Takhampunya","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib184","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0006-291X(91)91390-X","article-title":"Inactivation of ribonucleotide reductase by nitric oxide","volume":"179","author":"Lepoivre","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib185","first-page":"25","article-title":"S-nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide","volume":"48","author":"Colasanti","year":"1999","journal-title":"IUBMB Life"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib186","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2567.2000.00142.x","article-title":"Nitric oxide and virus infection","volume":"101","author":"Akaike","year":"2000","journal-title":"Immunology"},{"issue":"22","key":"10.1016\/j.niox.2022.08.003_bib187","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212166","article-title":"Delivery of nitric oxide in the cardiovascular system: implications for clinical diagnosis and therapy","volume":"22","author":"Ma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib188","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4049\/jimmunol.164.1.371","article-title":"IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-\u03b3 and nitric oxide synthetase 2","volume":"164","author":"van den Broek","year":"2000","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib189","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.188.8.1541","article-title":"Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice","volume":"188","author":"Karupiah","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.niox.2022.08.003_bib190","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/318087","article-title":"Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges","volume":"2012","author":"V\u00edte\u010dek","year":"2012","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib191","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1073\/pnas.93.6.2448","article-title":"Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals","volume":"93","author":"Akaike","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib192","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7150\/ijms.3880","article-title":"Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza","volume":"9","author":"Darwish","year":"2012","journal-title":"Int. J. Med. Sci."},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib193","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1084\/jem.185.9.1533","article-title":"Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2)","volume":"185","author":"Adler","year":"1997","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib194","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1172\/JCI119710","article-title":"Nitric oxide mediates murine cytomegalovirus-associated pneumonitis in lungs that are free of the virus","volume":"100","author":"Tanaka","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"3\u20134","key":"10.1016\/j.niox.2022.08.003_bib195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.vetimm.2010.03.022","article-title":"Nitric oxide is elicited and inhibits viral replication in pigs infected with porcine respiratory coronavirus but not porcine reproductive and respiratory syndrome virus","volume":"136","author":"Jung","year":"2010","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.niox.2022.08.003_bib196","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.668995","article-title":"Lower rate of daily smokers with symptomatic COVID-19: a monocentric self-report of smoking habit study","volume":"8","author":"Miyara","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.niox.2022.08.003_bib197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2020.06.005","article-title":"Nitric oxide dosed in short bursts at high concentrations may protect against Covid 19","volume":"103","author":"Hedenstierna","year":"2020","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib198","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12954-020-00437-5","article-title":"Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication","volume":"18","author":"Farsalinos","year":"2021","journal-title":"Harm Reduct. J."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib199","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jinf.2021.05.009","article-title":"Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection","volume":"83","author":"Winchester","year":"2021","journal-title":"J. Infect."},{"key":"10.1016\/j.niox.2022.08.003_bib200","series-title":"A Feasibility Trial to Evaluate the Composite Efficacy of Inhaled Nitric Oxide in the Treatment of Covid 19 Pneumonia : Impact on Viral Load and Clinical Outcomes, medRxiv","author":"Moni","year":"2021"},{"issue":"15","key":"10.1016\/j.niox.2022.08.003_bib201","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1080\/07391102.2020.1790038","article-title":"Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis","volume":"39","author":"Al-Sehemi","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib202","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/HJH.0000000000002508","volume":"38","author":"Zanoli","year":"2020","journal-title":"J. Hypertens."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib203","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib204","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/cvr\/cvs100","article-title":"Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis","volume":"94","author":"Momi","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.phrs.2009.06.002","article-title":"Ibuprofen\u2013arginine generates nitric oxide and has enhanced anti-inflammatory effects","volume":"60","author":"De Palma","year":"2009","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.niox.2022.08.003_bib206","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122092","article-title":"Nitric-oxide-releasing dexamethasone derivative NCX-1005 improves lung function and attenuates inflammation in experimental lavage-induced ARDS","volume":"13","author":"Kosutova","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib207","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0b013e3181b0f96f","article-title":"Augmentation of platelet and endothelial cell enos activity decreases sepsis-related neutrophil-endothelial cell interactions","volume":"33","author":"Khan","year":"2010","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib208","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41467-021-21907-9","article-title":"Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications","volume":"12","author":"Xiao","year":"2021","journal-title":"Nat. Commun."},{"issue":"1 Supplement","key":"10.1016\/j.niox.2022.08.003_bib209","article-title":"IL-6 influences the balance between M1 and M2 macrophages in a mouse model of irritant contact dermatitis","volume":"196","author":"Luckett-Chastain","year":"2016","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib210","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.2337\/db14-1668","article-title":"M2 macrophage polarization mediates anti-inflammatory effects of endothelial nitric oxide signaling","volume":"64","author":"Lee","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.niox.2022.08.003_bib211","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2020.09.025","article-title":"Control of systemic inflammation through early nitric oxide supplementation with nitric oxide releasing nanoparticles","volume":"161","author":"Williams","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2022.08.003_bib212","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.freeradbiomed.2015.02.016","article-title":"Inorganic nitrite attenuates NADPH oxidase-derived superoxide generation in activated macrophages via a nitric oxide-dependent mechanism","volume":"83","author":"Yang","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib213","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/01.CIR.83.6.2038","article-title":"Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction","volume":"83","author":"Frostell","year":"1991","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib214","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1161\/01.CIR.88.6.2884","article-title":"Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation","volume":"88","author":"Rimar","year":"1993","journal-title":"Circulation"},{"issue":"8776","key":"10.1016\/j.niox.2022.08.003_bib215","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(91)92033-X","article-title":"Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension","volume":"338","author":"Pepke-Zaba","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib216","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00000542-199303000-00005","article-title":"Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation","volume":"78","author":"Frostell","year":"1993","journal-title":"Anesthesiology"},{"issue":"8823","key":"10.1016\/j.niox.2022.08.003_bib217","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0140-6736(92)92687-B","article-title":"Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn","volume":"340","author":"Kinsella","year":"1992","journal-title":"Lancet"},{"issue":"8823","key":"10.1016\/j.niox.2022.08.003_bib218","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0140-6736(92)92686-A","article-title":"Inhaled nitric oxide in persistent pulmonary hypertension of the newborn","volume":"340","author":"Roberts","year":"1992","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib219","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199702273360902","article-title":"Inhaled nitric oxide and persistent pulmonary hypertension of the newborn","volume":"336","author":"Roberts","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib220","first-page":"196","article-title":"Use of inhaled nitric oxide in pediatric cardiac intensive care unit","volume":"44","author":"\u00d6zt\u00fcrk","year":"2016","journal-title":"Turk Kardiyol. Dernegi Arsivi"},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib221","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM200002173420704","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn","volume":"342","author":"Clark","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib222","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199702273360901","article-title":"Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure","volume":"336","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib223","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jpeds.2014.10.011","article-title":"Multicenter randomized controlled trial of inhaled nitric oxide for pediatric acute respiratory distress syndrome","volume":"166","author":"Bronicki","year":"2015","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib224","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJM199302113280605","article-title":"Inhaled nitric oxide for the adult respiratory distress syndrome","volume":"328","author":"Rossaint","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5492\/wjccm.v6.i1.74","article-title":"Comparison of inhaled milrinone, nitric oxide and prostacyclin in acute respiratory distress syndrome","volume":"6","author":"Albert","year":"2017","journal-title":"World J. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib226","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4037\/ajcc2015570","article-title":"Inhaled nitric oxide to improve oxygenation for safe critical care transport of adults with severe hypoxemia","volume":"24","author":"Teman","year":"2015","journal-title":"Am. J. Crit. Care"},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib227","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1203\/00006450-199704000-00002","article-title":"Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease","volume":"41","author":"Kinsella","year":"1997","journal-title":"Pediatr. Res."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib228","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ccm.2016.07.004","article-title":"Ventilator-induced lung injury","volume":"37","author":"Beitler","year":"2016","journal-title":"Clin. Chest Med."},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib229","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s001340050982","article-title":"Inhalation of nitric oxide in acute lung injury: results of a European multicentre study","volume":"25","author":"Lundin","year":"1999","journal-title":"Intensive Care Med."},{"issue":"13","key":"10.1016\/j.niox.2022.08.003_bib230","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.291.13.1603","article-title":"Low-dose inhaled nitric oxide in patients with acute lung InjuryA randomized controlled trial","volume":"291","author":"Taylor","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib231","doi-asserted-by":"crossref","DOI":"10.1213\/ANE.0b013e31820bd185","article-title":"Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis","volume":"112","author":"Afshari","year":"2011","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.niox.2022.08.003_bib232","article-title":"Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults","volume":"6","author":"Gebistorf","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib233","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0b013e3182a27909","article-title":"Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis","volume":"42","author":"Adhikari","year":"2014","journal-title":"Crit. Care Med."},{"issue":"10","key":"10.1016\/j.niox.2022.08.003_bib234","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1086\/425357","article-title":"Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing","volume":"39","author":"Chen","year":"2004","journal-title":"Clin. Infect. Dis. : an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib235","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1164\/rccm.202004-0937LE","article-title":"Outpatient inhaled nitric oxide in a patient with vasoreactive idiopathic pulmonary arterial hypertension and COVID-19 infection","volume":"202","author":"Zamanian","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib236","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/aas.13757","article-title":"Effects of inhaled nitric oxide in COVID-19\u2013induced ARDS \u2013 is it worthwhile?","volume":"65","author":"Lotz","year":"2021","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib237","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1016\/j.bja.2020.11.006","article-title":"Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia","volume":"126","author":"Garfield","year":"2021","journal-title":"Br. J. Anaesth."},{"issue":"11","key":"10.1016\/j.niox.2022.08.003_bib238","article-title":"Rescue treatment with high-dose gaseous nitric oxide in spontaneously breathing patients with severe coronavirus disease 2019","volume":"2","author":"Wiegand","year":"2020","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.niox.2022.08.003_bib239","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.niox.2021.08.003","article-title":"Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia","volume":"116","author":"Safaee Fakhr","year":"2021","journal-title":"Nitric Oxide"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib240","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/AOG.0000000000004128","article-title":"High concentrations of nitric oxide inhalation therapy in pregnant patients with severe coronavirus disease 2019 (COVID-19)","volume":"136","author":"Safaee Fakhr","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.niox.2022.08.003_bib241","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620933510","article-title":"Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients","volume":"14","author":"Parikh","year":"2020","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib242","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare10010162","article-title":"Clinical study on the efficacy and safety of arginine administered orally in association with other active ingredients for the prevention and treatment of sarcopenia in patients with COVID-19-related pneumonia, hospitalized in a sub-intensive care unit","volume":"10","author":"Bologna","year":"2022","journal-title":"Healthcare"},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib243","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1053\/j.jvca.2020.09.137","article-title":"Nitric oxide ventilation improves recirculation and right ventricular function during veno-venous extracorporeal membrane oxygenation in a COVID-19 patient","volume":"35","author":"Heuts","year":"2021","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib244","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ehf2.13023","article-title":"Implication of inhaled nitric oxide for the treatment of critically ill COVID-19 patients with pulmonary hypertension","volume":"8","author":"Feng","year":"2021","journal-title":"ESC Heart Failure"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib245","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1186\/s13054-020-03371-x","article-title":"Inhaled nitric oxide for critically ill Covid-19 patients: a prospective study","volume":"24","author":"Abou-Arab","year":"2020","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib246","first-page":"471","article-title":"Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome","volume":"39","author":"Cardinale","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.niox.2022.08.003_bib247","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jcrc.2020.08.007","article-title":"Inhaled nitric oxide in mechanically ventilated patients with COVID-19","volume":"60","author":"Ferrari","year":"2020","journal-title":"J. Crit. Care"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib248","article-title":"Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia","volume":"24","author":"Tavazzi","year":"2020","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib249","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.bja.2020.10.011","article-title":"Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome","volume":"126","author":"Longobardo","year":"2021","journal-title":"Br. J. Anaesth."},{"issue":"12 Suppl S","key":"10.1016\/j.niox.2022.08.003_bib250","doi-asserted-by":"crossref","first-page":"68s","DOI":"10.1016\/j.jacc.2004.02.031","article-title":"Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension","volume":"43","author":"Ghofrani","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-021-03885-y","article-title":"Sildenafil for treating patients with COVID-19 and perfusion mismatch: a pilot randomized trial","volume":"26","author":"Santamarina","year":"2022","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib252","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13613-020-00769-2","article-title":"Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome","volume":"10","author":"Bagate","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.niox.2022.08.003_bib253","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.655763","article-title":"Use of almitrine and inhaled nitric oxide in ARDS due to COVID-19","volume":"8","author":"Laghlam","year":"2021","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib254","doi-asserted-by":"crossref","first-page":"H1829","DOI":"10.1152\/ajpheart.00230.2009","article-title":"eNOS uncoupling and endothelial dysfunction in aged vessels","volume":"297","author":"Yang","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib255","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1471-4159.2012.07872.x","article-title":"Uncoupling of eNOS causes superoxide anion production and impairs NO signaling in the cerebral microvessels of hph-1 mice","volume":"122","author":"Santhanam","year":"2012","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib256","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.ATV.0000168896.64927.bb","article-title":"Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase","volume":"25","author":"M\u00fcnzel","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.niox.2022.08.003_bib257","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2006.01.071","article-title":"Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats","volume":"47","author":"Li","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib258","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.HYP.0000018041.48432.B5","article-title":"Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels","volume":"39","author":"Guzik","year":"2002","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib259","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1089-8603(03)00028-4","article-title":"Enhanced vasoconstrictor responses in eNOS deficient mice","volume":"8","author":"Lamping","year":"2003","journal-title":"Nitric Oxide"},{"issue":"6546","key":"10.1016\/j.niox.2022.08.003_bib260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/377239a0","article-title":"Hypertension in mice lacking the gene for endothelial nitric oxide synthase","volume":"377","author":"Huang","year":"1995","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib261","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1161\/01.CIR.91.6.1732","article-title":"Impaired endothelium-dependent vasodilation in patients with essential hypertension","volume":"91","author":"Panza","year":"1995","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib262","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/HYPERTENSIONAHA.116.08964","article-title":"Impaired hydrogen sulfide\u2013mediated vasodilation contributes to microvascular endothelial dysfunction in hypertensive adults","volume":"69","author":"Greaney","year":"2017","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib263","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/HJH.0000000000000587","article-title":"Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension","volume":"33","author":"Li","year":"2015","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib264","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.CIR.86.4.1302","article-title":"Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries","volume":"86","author":"Yao","year":"1992","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib265","doi-asserted-by":"crossref","DOI":"10.3390\/ph14070695","article-title":"Soluble angiotensin converting enzyme 2 (ACE2) is upregulated and soluble endothelial nitric oxide synthase (eNOS) is downregulated in COVID-19-induced acute respiratory distress syndrome (ARDS)","volume":"14","author":"Vassiliou","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib266","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4103\/0970-9185.142799","article-title":"Sodium nitroprusside in 2014: a clinical concepts review","volume":"30","author":"Hottinger","year":"2014","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"issue":"19","key":"10.1016\/j.niox.2022.08.003_bib267","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.jacc.2017.09.1064","article-title":"The role of nitroglycerin and other nitrogen oxides in cardiovascular therapeutics","volume":"70","author":"Divakaran","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib268","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI118338","article-title":"Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative","volume":"96","author":"Wallace","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib269","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1055\/a-1551-3756","article-title":"Candidate psychotropics against SARS - CoV - 2: a narrative review","volume":"55","author":"Khosravi","year":"2022","journal-title":"Pharmacopsychiatry"},{"issue":"22","key":"10.1016\/j.niox.2022.08.003_bib270","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial","volume":"324","author":"Lenze","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib271","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/a-1641-0357","article-title":"Anti-SARS-CoV-2 action of fluvoxamine may be mediated by endothelial nitric oxide synthase","volume":"55","author":"Papadopoulos","year":"2022","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib272","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00134-021-06593-x","article-title":"Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis","volume":"48","author":"Nunez","year":"2022","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib273","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1021\/acsabm.9b00237","article-title":"Catalyzed nitric oxide release via Cu nanoparticles leads to an increase in antimicrobial effects and hemocompatibility for short-term extracorporeal circulation","volume":"2","author":"Douglass","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib274","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1021\/acsbiomaterials.6b00622","article-title":"Reduction of thrombosis and bacterial infection via controlled nitric oxide (NO) release from S-nitroso-N-acetylpenicillamine (SNAP) impregnated CarboSil intravascular catheters","volume":"3","author":"Wo","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.niox.2022.08.003_bib275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.11.003","article-title":"Inorganic nitrite and nitrate in cardiovascular therapy: a better alternative to organic nitrates as nitric oxide donors?","volume":"102","author":"M\u00fcnzel","year":"2018","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.niox.2022.08.003_bib276","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.niox.2019.09.007","article-title":"Nitric oxide-loaded chitosan nanoparticles as an innovative antileishmanial platform","volume":"93","author":"Cabral","year":"2019","journal-title":"Nitric Oxide"},{"issue":"18","key":"10.1016\/j.niox.2022.08.003_bib277","doi-asserted-by":"crossref","first-page":"15254","DOI":"10.1021\/acsami.7b01408","article-title":"Tunable nitric oxide release from S-nitroso-N-acetylpenicillamine via catalytic copper nanoparticles for biomedical applications","volume":"9","author":"Pant","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"10","key":"10.1016\/j.niox.2022.08.003_bib278","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/jid.2009.95","article-title":"Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection","volume":"129","author":"Martinez","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib279","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acsbiomaterials.9b01384","article-title":"Mode of nitric oxide delivery affects antibacterial action","volume":"6","author":"Hall","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.niox.2022.08.003_bib280","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198202","article-title":"Nitric oxide (NO) and nanoparticles \u2013 potential small tools for the war against COVID-19 and other human coronavirus infections","volume":"291","author":"Pieretti","year":"2021","journal-title":"Virus Res."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib281","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1039\/D0NR07484E","article-title":"Advanced nitric oxide donors: chemical structure of NO drugs, NO nanomedicines and biomedical applications","volume":"13","author":"Yang","year":"2021","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib282","article-title":"Nitric oxide: the missing factor in COVID-19 severity?","volume":"10","author":"Nikolaidis","year":"2022","journal-title":"Med. Sci."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib283","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1039\/D0NJ03823G","article-title":"Nitric oxide as a therapeutic option for COVID-19 treatment: a concise perspective","volume":"45","author":"Mir","year":"2021","journal-title":"New J. Chem."},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib284","doi-asserted-by":"crossref","DOI":"10.3390\/nano10091699","article-title":"The natural-mineral-based novel nanomaterial IFMC increases intravascular nitric oxide without its intake: implications for COVID-19 and beyond","volume":"10","author":"Akiyama","year":"2020","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib285","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sxmr.2020.08.006","article-title":"Could oral phosphodiesterase 5 inhibitors have a potential adjuvant role in combating COVID-19 infection?","volume":"9","author":"Mostafa","year":"2021","journal-title":"Sex Med Rev"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib286","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191030","article-title":"Acute ingestion of beetroot juice increases exhaled nitric oxide in healthy individuals","volume":"13","author":"Kroll","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib287","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.pa.32.040192.000545","article-title":"Toxicology of hydrogen sulfide","volume":"32","author":"Reiffenstein","year":"1992","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib288","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J. Neurosci."},{"issue":"21","key":"10.1016\/j.niox.2022.08.003_bib289","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1093\/emboj\/20.21.6008","article-title":"The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener","volume":"20","author":"Zhao","year":"2001","journal-title":"EMBO J."},{"issue":"39","key":"10.1016\/j.niox.2022.08.003_bib290","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1073\/pnas.0705891104","article-title":"Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function","volume":"104","author":"Elrod","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib291","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.redox.2013.05.001","article-title":"A tale of two gases: NO and H2S, foes or friends for life?","volume":"1","author":"Kolluru","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.niox.2022.08.003_bib292","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bcp.2017.11.019","article-title":"Gasotransmitter hydrogen sulfide signaling in neuronal health and disease","volume":"149","author":"Paul","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"5901","key":"10.1016\/j.niox.2022.08.003_bib293","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.1162667","article-title":"H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase","volume":"322","author":"Yang","year":"2008","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib294","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/MN:26:1:013","article-title":"Hydrogen sulfide as a neuromodulator","volume":"26","author":"Kimura","year":"2002","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib295","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1165\/rcmb.2017-0114TR","article-title":"Hydrogen sulfide: a novel player in airway development, pathophysiology of respiratory diseases, and antiviral defenses","volume":"57","author":"Bazhanov","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib296","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/ars.2011.4349","article-title":"Role of cystathionine \u03b3-lyase\/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?","volume":"17","author":"Pan","year":"2012","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.niox.2022.08.003_bib297","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.phrs.2016.08.026","article-title":"Regulation and role of endogenously produced hydrogen sulfide in angiogenesis","volume":"113","author":"Katsouda","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib298","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.resp.2012.03.009","article-title":"The message in the air: hydrogen sulfide metabolism in chronic respiratory diseases","volume":"184","author":"Chen","year":"2012","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib299","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrgastro.2012.85","article-title":"Contributions of the microbial hydrogen economy to colonic homeostasis","volume":"9","author":"Carbonero","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"21","key":"10.1016\/j.niox.2022.08.003_bib300","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1093\/emboj\/20.21.6008","article-title":"The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener","volume":"20","author":"Zhao","year":"2001","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib301","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-7827-7-10","article-title":"The endogenous production of hydrogen sulphide in intrauterine tissues","volume":"7","author":"Patel","year":"2009","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.niox.2022.08.003_bib302","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1873962","article-title":"Antioxidant and cell-signaling functions of hydrogen sulfide in the central nervous system","author":"Shefa","year":"2018","journal-title":"Oxid Med Cell Longev 2018"},{"issue":"39","key":"10.1016\/j.niox.2022.08.003_bib303","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0902952106","article-title":"No facilitator required for membrane transport of hydrogen sulfide","volume":"106","author":"Mathai","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib304","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/bph.13825","article-title":"Protein S-sulfhydration by hydrogen sulfide in cardiovascular system","volume":"175","author":"Meng","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib305","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/ki.2009.221","article-title":"Hydrogen sulfide: a new EDRF","volume":"76","author":"Wang","year":"2009","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.niox.2022.08.003_bib306","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/CIRCRESAHA.111.240242","article-title":"Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels","volume":"109","author":"Mustafa","year":"2011","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib307","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.yjmcc.2006.10.011","article-title":"eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?","volume":"42","author":"Kukreja","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib308","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1471-4159.2004.02617.x","article-title":"The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite \u2018scavenger","volume":"90","author":"Whiteman","year":"2004","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib309","first-page":"134","article-title":"Advances in the diagnosis of sepsis: hydrogen sulfide as a prognostic marker of septic shock severity","volume":"28","author":"Ko\u0161ir","year":"2017","journal-title":"EJIFCC"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib310","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1042\/CS20080021","article-title":"Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation","volume":"115","author":"Esechie","year":"2008","journal-title":"Clin. Sci. (Lond.)"},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib311","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/j.gastro.2005.07.060","article-title":"Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs","volume":"129","author":"Fiorucci","year":"2005","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.niox.2022.08.003_bib312","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","article-title":"Hydrogen sulfide is an endogenous modulator of leukocyte\u2010mediated inflammation","volume":"20","year":"2006","journal-title":"Faseb. J."},{"key":"10.1016\/j.niox.2022.08.003_bib313","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-12-145","article-title":"Sulfur compounds block MCP-1 production by Mycoplasma fermentans-infected macrophages through NF-\u03baB inhibition","volume":"12","author":"Benedetti","year":"2014","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib314","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.freeradbiomed.2006.03.021","article-title":"Hydrogen sulfide inhibits nitric oxide production and nuclear factor-\u03baB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide","volume":"41","author":"Oh","year":"2006","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib315","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1096\/fj.04-3583fje","article-title":"Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse","volume":"19","author":"Li","year":"2005","journal-title":"Faseb. J."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib316","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10030383","article-title":"Harnessing the benefits of endogenous hydrogen sulfide to reduce cardiovascular disease","volume":"10","author":"Casin","year":"2021","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib317","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0163-4453(03)00043-4","article-title":"Changes in arterial hydrogen sulfide (H2S) content during septic shock and endotoxin shock in rats","volume":"47","author":"Hui","year":"2003","journal-title":"J. Infect."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib318","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ajpath.2012.12.008","article-title":"The inhibitory role of hydrogen sulfide in airway hyperresponsiveness and inflammation in a mouse model of asthma","volume":"182","author":"Zhang","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib319","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cyto.2008.11.009","article-title":"Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma","volume":"45","author":"Chen","year":"2009","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib320","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1440-1843.2009.01550.x","article-title":"Serum hydrogen sulfide as a novel marker predicting bacterial involvement in patients with community-acquired lower respiratory tract infections","volume":"14","author":"Chen","year":"2009","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib321","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/sj.bjp.0706367","article-title":"Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia","volume":"146","author":"Collin","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib322","doi-asserted-by":"crossref","first-page":"L1193","DOI":"10.1152\/ajplung.00489.2005","article-title":"Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse","volume":"290","author":"Zhang","year":"2006","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.niox.2022.08.003_bib323","doi-asserted-by":"crossref","unstructured":"H. Li, Y. Ma, O. Escaffre, T. Ivanciuc, N. Komaravelli, P. Kelley John, C. Coletta, C. Szabo, B. Rockx, P. Garofalo Roberto, A. Casola, S.R. Ross, Role of hydrogen sulfide in paramyxovirus infections, J. Virol. 89(10) 5557-5568.","DOI":"10.1128\/JVI.00264-15"},{"key":"10.1016\/j.niox.2022.08.003_bib324","first-page":"633","volume":"vol. 54","author":"Renieris","year":"2020"},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib325","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bcp.2012.10.019","article-title":"Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras","volume":"85","author":"Kashfi","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"21","key":"10.1016\/j.niox.2022.08.003_bib326","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1111\/bph.15230","article-title":"Anti-inflammatory and antiviral roles of hydrogen sulfide: rationale for considering H2S donors in COVID-19 therapy","volume":"177","author":"Citi","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib327","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1089\/ars.2012.4565","article-title":"VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045-Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells","volume":"19","author":"Tao","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.niox.2022.08.003_bib328","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ebiom.2019.06.037","article-title":"Fatty-acid receptor CD36 functions as a hydrogen sulfide-targeted receptor with its Cys333-Cys272 disulfide bond serving as a specific molecular switch to accelerate gastric cancer metastasis","volume":"45","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.niox.2022.08.003_bib329","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2019.00128","article-title":"Biological effects of thermal water-associated hydrogen sulfide on human airways and associated immune cells: implications for respiratory diseases","volume":"7","author":"Viegas","year":"2019","journal-title":"Front. Public Health"},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib330","doi-asserted-by":"crossref","first-page":"R636","DOI":"10.1152\/ajpregu.00489.2014","article-title":"Hydrogen sulfide decreases \u03b2-adrenergic agonist-stimulated lung liquid clearance by inhibiting ENaC-mediated transepithelial sodium absorption","volume":"308","author":"Agn\u00e9","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.niox.2022.08.003_bib331","doi-asserted-by":"crossref","DOI":"10.1038\/srep41029","article-title":"Broad-range antiviral activity of hydrogen sulfide against highly pathogenic RNA viruses","volume":"7","author":"Bazhanov","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.niox.2022.08.003_bib332","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1128\/JVI.00264-15","article-title":"Role of hydrogen sulfide in paramyxovirus infections","volume":"89","author":"Li","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.niox.2022.08.003_bib333","series-title":"Sulfur-containing compounds as hydrogen sulfide and broad-spectrum antiviral agents","first-page":"122","author":"Pacheco","year":"2017"},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib334","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1165\/rcmb.2015-0385OC","article-title":"Hydrogen sulfide is an antiviral and antiinflammatory endogenous gasotransmitter in the airways. Role in respiratory syncytial virus infection","volume":"55","author":"Ivanciuc","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib335","doi-asserted-by":"crossref","DOI":"10.3390\/v10050249","article-title":"Thiol-activated hydrogen sulfide donors antiviral and anti-inflammatory activity in respiratory syncytial virus infection","volume":"10","author":"Bazhanov","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib336","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ars.2008.2282","article-title":"Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria","volume":"12","author":"Kimura","year":"2009","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.niox.2022.08.003_bib337","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01239","article-title":"Glutathione fine-tunes the innate immune response toward antiviral pathways in a macrophage cell line independently of its antioxidant properties","volume":"8","author":"Diotallevi","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib338","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0166-3542(95)00008-A","article-title":"Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication","volume":"27","author":"Palamara","year":"1995","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib339","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/0006-291X(92)91343-O","article-title":"Glutathione inhibits replication and expression of viral proteins in cultured cells infected with sendai virus","volume":"188","author":"Garaci","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib340","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0891-5849(03)00023-6","article-title":"Inhibition of influenza infection by glutathione","volume":"34","author":"Cai","year":"2003","journal-title":"Free Radic. Biol. Med."},{"issue":"19","key":"10.1016\/j.niox.2022.08.003_bib341","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1128\/JVI.76.19.9920-9933.2002","article-title":"Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein \u03bc1 mediates membrane disruption","volume":"76","author":"Chandran","year":"2002","journal-title":"J. Virol."},{"issue":"1\u20134","key":"10.1016\/j.niox.2022.08.003_bib342","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00709-010-0152-6","article-title":"Mechanisms of viral entry: sneaking in the front door","volume":"244","author":"Thorley","year":"2010","journal-title":"Protoplasma"},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib343","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00726-009-0363-3","article-title":"Virus entry paradigms","volume":"41","author":"Kalia","year":"2011","journal-title":"Amino Acids"},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib344","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091273","article-title":"Hydrogen sulfide inhibits TMPRSS2 in human airway epithelial cells: implications for SARS-CoV-2 infection","volume":"9","author":"Pozzi","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.niox.2022.08.003_bib345","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7866992","article-title":"The antiviral roles of hydrogen sulfide by blocking the interaction between SARS-CoV-2 and its potential cell surface receptors","volume":"2021","author":"Dai","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib346","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12967-020-02430-9","article-title":"Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)","volume":"18","author":"Kim","year":"2020","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib347","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/thx.46.1.39","article-title":"Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine","volume":"46","author":"Bridgeman","year":"1991","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib348","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chembiol.2018.01.011","article-title":"N-acetyl cysteine functions as a fast-acting antioxidant by triggering intracellular H2S and sulfane sulfur production","volume":"25","author":"Ezeri\u0146a","year":"2018","journal-title":"Cell Chemical Biology"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib349","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100560R","article-title":"Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs","volume":"35","author":"Man\u010dek-Keber","year":"2021","journal-title":"Faseb. J."},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib350","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091107","article-title":"H2S as a bridge linking inflammation, oxidative stress and endothelial biology: a possible defense in the fight against SARS-CoV-2 infection?","volume":"9","author":"Gorini","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib351","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3892\/mmr.2014.2901","article-title":"GYY4137, a hydrogen sulfide-releasing molecule, inhibits the inflammatory response by suppressing the activation of nuclear factor-kappa B and mitogen-activated protein kinases in Coxsackie virus B3-infected rat cardiomyocytes","volume":"11","author":"Wu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib352","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.freeradbiomed.2010.10.705","article-title":"Reactivity of hydrogen sulfide with peroxynitrite and other oxidants of biological interest","volume":"50","author":"Carballal","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2022.08.003_bib353","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2014.12.017","article-title":"Insights into the mechanism of the reaction between hydrogen sulfide and peroxynitrite","volume":"80","author":"Cuevasanta","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2022.08.003_bib354","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2153745","article-title":"Hydrogen sulfide protects against chronic unpredictable mild stress-induced oxidative stress in Hippocampus by upregulation of BDNF-TrkB pathway","volume":"2016","author":"Hu","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib355","first-page":"5097","article-title":"Hydrogen sulfide accelerates wound healing in diabetic rats","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib356","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/hr.2014.125","article-title":"Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice","volume":"38","author":"Al-Magableh","year":"2015","journal-title":"Hypertens. Res."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib357","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019766","article-title":"Hydrogen sulfide attenuated tumor necrosis factor-\u03b1-induced inflammatory signaling and dysfunction in vascular endothelial cells","volume":"6","author":"Pan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2022.08.003_bib358","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9647809","article-title":"Hydrogen sulfide alleviates lipopolysaccharide-induced diaphragm dysfunction in rats by reducing apoptosis and inflammation through ROS\/MAPK and TLR4\/NF-\u03baB signaling pathways","author":"Zhang","year":"2018","journal-title":"Oxid Med Cell Longev 2018"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib359","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33101-x","article-title":"Hydrogen sulfide limits neutrophil transmigration, inflammation, and oxidative burst in lipopolysaccharide-induced acute lung injury","volume":"8","author":"Faller","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib360","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/bph.12246","article-title":"The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-\/-) mice","volume":"169","author":"Liu","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib361","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/ars.2017.7195","article-title":"Sulfhydrated sirtuin-1 increasing its deacetylation activity is an essential epigenetics mechanism of anti-atherogenesis by hydrogen sulfide","volume":"30","author":"Du","year":"2018","journal-title":"Antioxidants Redox Signal."},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib362","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3181\/0712-RM-354","article-title":"Regulatory effects of hydrogen sulfide on IL-6, IL-8 and IL-10 levels in the plasma and pulmonary tissue of rats with acute lung injury","volume":"233","author":"Li","year":"2008","journal-title":"Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib363","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cellsig.2010.10.017","article-title":"Role of nitric oxide produced by iNOS through NF-\u03baB pathway in migration of cerebellar granule neurons induced by Lipopolysaccharide","volume":"23","author":"Arias-Salvatierra","year":"2011","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib364","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/ars.2011.4363","article-title":"Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice","volume":"17","author":"Tokuda","year":"2012","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib365","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3892\/etm.2015.2482","article-title":"Protective effects of hydrogen sulfide inhalation on oxidative stress in rats with cotton smoke inhalation-induced lung injury","volume":"10","author":"Han","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib366","doi-asserted-by":"crossref","first-page":"L896","DOI":"10.1152\/ajplung.00053.2006","article-title":"Role of substance P in hydrogen sulfide-induced pulmonary inflammation in mice","volume":"291","author":"Bhatia","year":"2006","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"10","key":"10.1016\/j.niox.2022.08.003_bib367","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1089\/ars.2009.2899","article-title":"The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages","volume":"12","author":"Whiteman","year":"2009","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib368","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/ecp.10.134","article-title":"Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising","volume":"4","author":"Whiteman","year":"2011","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib369","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1186\/s12879-020-05681-5","article-title":"Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study","volume":"20","author":"Gong","year":"2020","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib370","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib371","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.niox.2022.08.003_bib372","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108544","article-title":"Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine","volume":"219","author":"Ibrahim","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.niox.2022.08.003_bib373","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/260465","article-title":"Acute respiratory distress syndrome: role of oleic acid-triggered lung injury and inflammation","volume":"2015","author":"Gon\u00e7alves-de-Albuquerque","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib374","doi-asserted-by":"crossref","DOI":"10.3760\/cma.j.issn.0366-6999.20120809","article-title":"Hydrogen sulfide donor regulates alveolar epithelial cell apoptosis in rats with acute lung injury","volume":"126","author":"Liu","year":"2013","journal-title":"Chinese Med J"},{"issue":"13","key":"10.1016\/j.niox.2022.08.003_bib375","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.7150\/ijbs.38315","article-title":"Hydrogen sulfide treatment alleviated ventilator-induced lung injury through regulation of autophagy and endoplasmic reticulum stress","volume":"15","author":"Ge","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.niox.2022.08.003_bib376","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s00134-010-2022-2","article-title":"Suspended animation inducer hydrogen sulfide is protective in an in vivo model of ventilator-induced lung injury","volume":"36","author":"Aslami","year":"2010","journal-title":"Intensive Care Med."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib377","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176649","article-title":"Pre- and posttreatment with hydrogen sulfide prevents ventilator-induced lung injury by limiting inflammation and oxidation","volume":"12","author":"Faller","year":"2017","journal-title":"PLoS One"},{"issue":"S 02","key":"10.1016\/j.niox.2022.08.003_bib378","article-title":"Pre- and posttreatment with hydrogen sulfide could improve perioperative management by limiting ventilator-induced lung injury","volume":"68","author":"Seiler","year":"2020","journal-title":"Thorac. Cardiovasc. Surg."},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib379","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000002440","article-title":"Hydrogen sulfide confers lung protection during mechanical ventilation via cyclooxygenase 2, 15-deoxy \u039412,14-prostaglandin J2, and peroxisome proliferator-activated receptor gamma","volume":"45","author":"Spassov","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.niox.2022.08.003_bib380","article-title":"Hydrogen sulfide prevents formation of reactive oxygen species through PI3K\/Akt signaling and limits ventilator-induced lung injury","author":"Spassov","year":"2017","journal-title":"Oxid Med Cell Longev 2017"},{"issue":"9\u201310","key":"10.1016\/j.niox.2022.08.003_bib381","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/01902148.2017.1381780","article-title":"Intravenous controlled-release hydrogen sulfide protects against ventilator-induced lung injury","volume":"43","author":"Wang","year":"2017","journal-title":"Exp. Lung Res."},{"issue":"7","key":"10.1016\/j.niox.2022.08.003_bib382","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102401","article-title":"Genetic targets of hydrogen sulfide in ventilator-induced lung injury \u2013 a microarray study","volume":"9","author":"Spassov","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib383","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/cts.13081","article-title":"Hydrogen sulfide donor protects against mechanical ventilation-induced atrophy and contractile dysfunction in the rat diaphragm","volume":"14","author":"Ichinoseki-Sekine","year":"2021","journal-title":"Clinical and Translational Science"},{"key":"10.1016\/j.niox.2022.08.003_bib384","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00782","article-title":"Hydrogen sulfide attenuates atherosclerosis in a partially ligated carotid artery mouse model via regulating angiotensin converting enzyme 2 expression","volume":"8","author":"Lin","year":"2017","journal-title":"Front. Physiol."},{"issue":"42","key":"10.1016\/j.niox.2022.08.003_bib385","article-title":"Experience of N-acetylcysteine airway management in the successful treatment of one case of critical condition with COVID-19: a case report","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.niox.2022.08.003_bib386","doi-asserted-by":"crossref","first-page":"21","DOI":"10.18093\/0869-0189-2021-31-1-21-29","article-title":"N-acetylcysteine as a part of complex treatment of moderate COVID-associated pneumonia","volume":"31","author":"Gaynitdinova","year":"2021","journal-title":"Pulmonologiya"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib387","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.eururo.2012.07.025","article-title":"Sildenafil effect on the human bladder involves the L-cysteine\/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors","volume":"62","author":"Fusco","year":"2012","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib388","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3109\/10715762.2016.1164311","article-title":"Hydrogen sulfide attenuates ferric chloride-induced arterial thrombosis in rats","volume":"50","author":"Qin","year":"2016","journal-title":"Free Radic. Res."},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib389","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1073\/pnas.1321871111","article-title":"Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent","volume":"111","author":"King","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"23","key":"10.1016\/j.niox.2022.08.003_bib390","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1073\/pnas.1202916109","article-title":"Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation","volume":"109","author":"Coletta","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib391","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15407\/fz61.06.003","article-title":"[Hydrogen sulfide donor, nahs, recovers constitutive no synthesis and endothelium-dependent relaxation of isolated aorta in old rats]","volume":"61","author":"Drachuk","year":"2015","journal-title":"Fiziol. Zh."},{"issue":"10","key":"10.1016\/j.niox.2022.08.003_bib392","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/ATVBAHA.110.209783","article-title":"Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity","volume":"30","author":"Bucci","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2022.08.003_bib393","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.phrs.2016.06.029","article-title":"Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide","volume":"111","author":"Zhou","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.niox.2022.08.003_bib394","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bcp.2018.03.025","article-title":"Cross-talk between endogenous H2S and NO accounts for vascular protective activity of the metal-nonoate Zn(PipNONO)Cl","volume":"152","author":"Monti","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib395","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/09537104.2016.1235693","article-title":"The effects of hydrogen sulfide on platelet-leukocyte aggregation and microvascular thrombolysis","volume":"28","author":"Grambow","year":"2017","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib396","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/09537104.2013.786823","article-title":"Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice","volume":"25","author":"Grambow","year":"2014","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib397","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.hlc.2014.05.019","article-title":"Hydrogen sulfide inhibits human platelet aggregation in vitro in part by interfering gap junction channels: effects of ACS14, a hydrogen sulfide-releasing aspirin, heart","volume":"24","author":"Gao","year":"2015","journal-title":"Lung and Circulation"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib398","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1016\/j.thromres.2013.07.010","article-title":"The anti-thrombotic effect of hydrogen sulfide is partly mediated by an upregulation of nitric oxide synthases","volume":"132","author":"Kram","year":"2013","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib399","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10030429","article-title":"Trends in H2S-donors chemistry and their effects in cardiovascular diseases","volume":"10","author":"Corvino","year":"2021","journal-title":"Antioxidants"},{"issue":"17","key":"10.1016\/j.niox.2022.08.003_bib400","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/cbic.201300552","article-title":"New biologically active hydrogen sulfide donors","volume":"14","author":"Roger","year":"2013","journal-title":"Chembiochem"},{"key":"10.1016\/j.niox.2022.08.003_bib401","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113931","article-title":"The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: a new era of customized medications","volume":"176","author":"Dillon","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.niox.2022.08.003_bib402","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1161\/ATVBAHA.112.300627","article-title":"Hydrogen sulfide\u2013releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo","volume":"32","author":"Pircher","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib403","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/ALN.0b013e31823306cf","article-title":"Protective and detrimental effects of sodium sulfide and hydrogen sulfide in murine ventilator-induced lung injury","volume":"115","author":"Francis","year":"2011","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib404","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/pr.117.014050","article-title":"International union of basic and clinical pharmacology. CII: pharmacological modulation of H(2)S levels: H(2)S donors and H(2)S biosynthesis inhibitors","volume":"69","author":"Szabo","year":"2017","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib405","doi-asserted-by":"crossref","DOI":"10.3390\/biom10020323","article-title":"Hydrogen sulfide in pharmacotherapy, beyond the hydrogen sulfide-donors","volume":"10","author":"Zaorska","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib406","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1006\/bbrc.1997.6878","article-title":"The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide","volume":"237","author":"Hosoki","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib407","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00029330-200803010-00010","article-title":"Effects of nitric oxide and hydrogen sulfide on the relaxation of pulmonary arteries in rats","volume":"121","author":"Wang","year":"2008","journal-title":"Chin. Med. J."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib408","doi-asserted-by":"crossref","first-page":"H474","DOI":"10.1152\/ajpheart.00013.2002","article-title":"H2S-induced vasorelaxation and underlying cellular and molecular mechanisms","volume":"283","author":"Zhao","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib409","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/FJC.0b013e31820eb7a1","article-title":"Hydrogen sulfide: a novel signaling molecule in the vascular system","volume":"58","author":"Liu","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib410","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tox.2006.12.023","article-title":"Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension","volume":"232","author":"Kubo","year":"2007","journal-title":"Toxicology"},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib411","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1139\/y03-077","article-title":"Modulation of endogenous production of H2S in rat tissues","volume":"81","author":"Zhao","year":"2003","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib412","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.bbrc.2006.04.162","article-title":"Impact of L-arginine on hydrogen sulfide\/cystathionine-gamma-lyase pathway in rats with high blood flow-induced pulmonary hypertension","volume":"345","author":"Yanfei","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib413","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10620-016-4377-x","article-title":"Nitric oxide and hydrogen sulfide interact when modulating gastric physiological functions in rodents","volume":"62","author":"Lucetti","year":"2017","journal-title":"Dig. Dis. Sci."},{"issue":"10","key":"10.1016\/j.niox.2022.08.003_bib414","doi-asserted-by":"crossref","DOI":"10.1097\/00004872-200310000-00015","article-title":"The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase","volume":"21","author":"Zhong","year":"2003","journal-title":"J. Hypertens."},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib415","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/sj.bjp.0706696","article-title":"Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat","volume":"147","author":"Anuar","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib416","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0162-0134(01)00335-X","article-title":"Characterization of NO binding to human cystathionine \u03b2-synthase:: possible implications of the effects of CO and NO binding to the human enzyme","volume":"87","author":"Taoka","year":"2001","journal-title":"J. Inorg. Biochem."},{"issue":"12","key":"10.1016\/j.niox.2022.08.003_bib417","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1074\/jbc.M113.507533","article-title":"NO\u2022 binds human cystathionine \u03b2-synthase quickly and tightly","volume":"289","author":"Vicente","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib418","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00726-010-0510-x","article-title":"Hydrogen sulfide: its production, release and functions","volume":"41","author":"Kimura","year":"2011","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib419","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2012.11.001","article-title":"Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells","volume":"48","author":"Kida","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.niox.2022.08.003_bib420","article-title":"Hydrogen sulfide increases nitric oxide production from endothelial cells by an akt-dependent mechanism","volume":"2","author":"Cardounel","year":"2011","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.niox.2022.08.003_bib421","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCULATIONAHA.112.000855","article-title":"H2S protects against pressure overload\u2013induced heart failure via upregulation of endothelial nitric oxide synthase","volume":"127","author":"Kondo","year":"2013","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.niox.2022.08.003_bib422","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1111\/bph.13815","article-title":"Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system","volume":"174","author":"Cirino","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib423","doi-asserted-by":"crossref","first-page":"R1608","DOI":"10.1152\/ajpregu.00207.2006","article-title":"Hydrogen sulfide downregulates the aortic l-arginine\/nitric oxide pathway in rats","volume":"293","author":"Geng","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"24","key":"10.1016\/j.niox.2022.08.003_bib424","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.lfs.2013.10.007","article-title":"Cardioprotection of H2S by downregulating iNOS and upregulating HO-1 expression in mice with CVB3-induced myocarditis","volume":"93","author":"Hua","year":"2013","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097315","article-title":"Hydrogen sulfide releasing aspirin, ACS14, attenuates high glucose-induced increased methylglyoxal and oxidative stress in cultured vascular smooth muscle cells","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib426","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tox.2007.08.087","article-title":"Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase","volume":"241","author":"Kubo","year":"2007","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib427","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bbrc.2006.05.002","article-title":"Hydrogen sulfide potentiates interleukin-1\u03b2-induced nitric oxide production via enhancement of extracellular signal-regulated kinase activation in rat vascular smooth muscle cells","volume":"345","author":"Jeong","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2022.08.003_bib428","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6904327","article-title":"Interaction of hydrogen sulfide with nitric oxide in the cardiovascular system","author":"Nagpure","year":"2016","journal-title":"Oxid Med Cell Longev 2016"},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib429","doi-asserted-by":"crossref","DOI":"10.1038\/srep45995","article-title":"Polysulfides (H2Sn) produced from the interaction of hydrogen sulfide (H2S) and nitric oxide (NO) activate TRPA1 channels","volume":"7","author":"Miyamoto","year":"2017","journal-title":"Sci. Rep."},{"issue":"34","key":"10.1016\/j.niox.2022.08.003_bib430","doi-asserted-by":"crossref","first-page":"E4651","DOI":"10.1073\/pnas.1509277112","article-title":"Key bioactive reaction products of the NO\/H2S interaction are S\/N-hybrid species, polysulfides, and nitroxyl","volume":"112","author":"Cortese-Krott","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.niox.2022.08.003_bib431","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.redox.2013.12.031","article-title":"Nitrosopersulfide (SSNO\u2212) accounts for sustained NO bioactivity of S-nitrosothiols following reaction with sulfide","volume":"2","author":"Cortese-Krott","year":"2014","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib432","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbrc.2006.02.154","article-title":"Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide","volume":"343","author":"Whiteman","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib433","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/sj.bjp.0706906","article-title":"Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?","volume":"149","author":"Ali","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2022.08.003_bib434","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.niox.2014.12.008","article-title":"The reaction products of sulfide and S-nitrosoglutathione are potent vasorelaxants","volume":"46","author":"Berenyiova","year":"2015","journal-title":"Nitric Oxide"},{"issue":"3","key":"10.1016\/j.niox.2022.08.003_bib435","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/cvr\/cvq248","article-title":"Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl","volume":"88","author":"Yong","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.niox.2022.08.003_bib436","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2013.02.025","article-title":"Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity","volume":"60","author":"Miller","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.niox.2022.08.003_bib437","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034892","article-title":"Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib438","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pharmthera.2006.11.002","article-title":"The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO","volume":"113","author":"Paolocci","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.niox.2022.08.003_bib439","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10555-021-10017-z","article-title":"COVID-19 and cancer: start the resolution","volume":"41","author":"Barksdale","year":"2022","journal-title":"Cancer Metastasis Rev."},{"issue":"10229","key":"10.1016\/j.niox.2022.08.003_bib440","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.niox.2022.08.003_bib441","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.niox.2022.08.003_bib442","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107879","article-title":"Resolution of inflammation: an organizing principle in biology and medicine","volume":"227","author":"Panigrahy","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"7503","key":"10.1016\/j.niox.2022.08.003_bib443","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.niox.2022.08.003_bib444","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ajpath.2020.06.010","article-title":"Eicosanoids: the overlooked storm in coronavirus disease 2019 (COVID-19)?","volume":"190","author":"Hammock","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.niox.2022.08.003_bib445","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib446","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10555-020-09889-4","article-title":"Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?","volume":"39","author":"Panigrahy","year":"2020","journal-title":"Cancer Metastasis Rev."},{"issue":"35","key":"10.1016\/j.niox.2022.08.003_bib447","doi-asserted-by":"crossref","first-page":"12746","DOI":"10.1073\/pnas.1404372111","article-title":"Phospholipase A2 regulates eicosanoid class switching during inflammasome activation","volume":"111","author":"Norris","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib448","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/dmd.115.063339","article-title":"The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain","volume":"43","author":"Kodani","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.niox.2022.08.003_bib449","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/bcp.12855","article-title":"Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor","volume":"81","author":"Lazaar","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.niox.2022.08.003_bib450","series-title":"Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study","author":"University Hospital Southampton","year":"2012"},{"issue":"Suppl 1","key":"10.1016\/j.niox.2022.08.003_bib451","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2014-306237.367","article-title":"G385 ratno \u2013 reducing antibiotic tolerance using nitric oxide in cystic fibrosis: report of a proof of concept clinical trial","volume":"99","author":"Cathie","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.niox.2022.08.003_bib452","series-title":"Children's Medical Center","article-title":"Evaluation of the safety and tolerability of inhaled nitric oxide to subjects with cystic fibrosis","author":"Beyond Air","year":"2015"},{"key":"10.1016\/j.niox.2022.08.003_bib453","series-title":"Mallinckrodt, Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis","author":"Novoteris","year":"2020"},{"key":"10.1016\/j.niox.2022.08.003_bib454","series-title":"Phase II Study of a Nebulised Nitric Oxide Generating Solution in Patients with Cystic Fibrosis","author":"Papworth Hospital","year":"2022"},{"key":"10.1016\/j.niox.2022.08.003_bib455","series-title":"A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients","author":"Beyond Air","year":"2021"},{"issue":"2","key":"10.1016\/j.niox.2022.08.003_bib456","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jcf.2019.05.002","article-title":"Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection","volume":"19","author":"Bentur","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.niox.2022.08.003_bib457","author":"Akron","year":"2008"},{"key":"10.1016\/j.niox.2022.08.003_bib458","author":"Schmidhofer","year":"2021"},{"key":"10.1016\/j.niox.2022.08.003_bib459","series-title":"Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection","author":"Sanotize","year":"2022"},{"key":"10.1016\/j.niox.2022.08.003_bib460","unstructured":"C. Salmaniya Medical, Phase 3 clinical study evaluating nitric oxide nasal spray (NONS) efficacy to treat and prevent the exacerbation of infection in individuals with documented asymptomatic or mild COVID-19, 2022."},{"key":"10.1016\/j.niox.2022.08.003_bib461","volume":"vol. 2","author":"Thirty","year":"2023"},{"key":"10.1016\/j.niox.2022.08.003_bib462","series-title":"Respiratory, PREvent Viral Exposure aNd Transmission Study: a SARS-CoV-2 PEP Study","author":"Thirty","year":"2022"},{"key":"10.1016\/j.niox.2022.08.003_bib463","series-title":"Inhaled NO for the Treatment of Viral Pneumonia in Adults","author":"Beyond Air","year":"2022"},{"key":"10.1016\/j.niox.2022.08.003_bib464","series-title":"The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African","year":"2021"},{"key":"10.1016\/j.niox.2022.08.003_bib465","series-title":"National Research Medical Center of the Russian Academy of, U. Siberian State Medical, Nitric Oxide Therapy for COVID-19 Patients with Oxygen Requirement","author":"Tomsk","year":"2021"},{"issue":"Suppl_1","key":"10.1016\/j.niox.2022.08.003_bib466","doi-asserted-by":"crossref","DOI":"10.1161\/circ.144.suppl_1.11986","article-title":"Abstract 11986: a safety study of intermittent versus continuous inhaled no therapy in spontaneously breathing COVID-19 patients: a randomized controlled trial","volume":"144","author":"Kamenshchikov","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2022.08.003_bib467","series-title":"Respiratory, A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants with COVID-19","author":"Thirty","year":"2021"},{"key":"10.1016\/j.niox.2022.08.003_bib468","series-title":"Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2","author":"Beyond Air","year":"2020"},{"key":"10.1016\/j.niox.2022.08.003_bib469","series-title":"High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients)","author":"University Health Network","year":"2021"},{"key":"10.1016\/j.niox.2022.08.003_bib470","series-title":"Nitric Oxide Releasing Solutions to Prevent and Treat Mild\/Moderate COVID-19 Infection","author":"Sanotize","year":"2021"},{"key":"10.1016\/j.niox.2022.08.003_bib471","series-title":"NO Prevention of COVID-19 for Healthcare Providers","author":"Massachusetts General","year":"2021"},{"key":"10.1016\/j.niox.2022.08.003_bib472","unstructured":"H. Massachusetts General, H. Xijing, O.M.P. Fondazione Irccs Ca' Granda, H. Niguarda, Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-vol. 19, 2021."},{"key":"10.1016\/j.niox.2022.08.003_bib473","series-title":"Nitric Oxide Gas Inhalation Therapy for Mild\/Moderate COVID-19","author":"Massachusetts General","year":"2021"},{"key":"10.1016\/j.niox.2022.08.003_bib474","series-title":"Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2","author":"Beyond Air","year":"2020"},{"key":"10.1016\/j.niox.2022.08.003_bib475","series-title":"Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection","author":"Sanotize","year":"2021"},{"key":"10.1016\/j.niox.2022.08.003_bib476","volume":"vol. 19","author":"Bellerophon Pulse","year":"2020"},{"key":"10.1016\/j.niox.2022.08.003_bib477","series-title":"Treatment of Lung Injury from COVID-19 Infection with Intravenous Sodium Nitrite","author":"Hope","year":"2020"},{"key":"10.1016\/j.niox.2022.08.003_bib478","unstructured":"A. Roger, T. Bellerophon, M. University of, iNOPulse for COVID-19, 2021."},{"key":"10.1016\/j.niox.2022.08.003_bib479","volume":"vol. 19","author":"Tufts","year":"2020"},{"key":"10.1016\/j.niox.2022.08.003_bib480","series-title":"Nitric Oxide Inhalation Therapy for COVID-19 Infections in the","author":"Massachusetts General","year":"2021"},{"key":"10.1016\/j.niox.2022.08.003_bib481","series-title":"Nitric Solutions, Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung","author":"Chris","year":"2021"}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860322000866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860322000866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:35:48Z","timestamp":1778589348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860322000866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":481,"alternative-id":["S1089860322000866"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2022.08.003","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of NO and H2S donating platforms in managing COVID-19: Rationale and promise","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2022.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}